Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 12.65B | 12.63B | 12.49B | 12.21B | 12.37B | 11.79B |
Gross Profit | 6.25B | 10.69B | 5.08B | 4.91B | 5.08B | 4.42B |
EBITDA | 1.48B | 1.07B | 1.54B | 1.74B | 1.93B | 2.02B |
Net Income | -192.00M | -516.00M | -133.00M | 46.00M | 230.00M | 511.00M |
Balance Sheet | ||||||
Total Assets | 13.64B | 14.05B | 14.46B | 14.67B | 15.22B | 16.01B |
Cash, Cash Equivalents and Short-Term Investments | 456.00M | 37.00M | 38.00M | 118.00M | 507.00M | 1.68B |
Total Debt | 649.00M | 12.10B | 12.17B | 12.39B | 12.82B | 12.88B |
Total Liabilities | 14.74B | 15.37B | 15.28B | 15.40B | 16.03B | 17.06B |
Stockholders Equity | -1.10B | -1.91B | -1.39B | -1.37B | -1.37B | -1.63B |
Cash Flow | ||||||
Free Cash Flow | 226.00M | 120.00M | -257.00M | -124.00M | -603.00M | 1.74B |
Operating Cash Flow | 490.00M | 480.00M | 210.00M | 300.00M | -131.00M | 2.18B |
Investing Cash Flow | 718.00M | -275.00M | -26.00M | -259.00M | -524.00M | 177.00M |
Financing Cash Flow | -792.00M | -206.00M | -264.00M | -430.00M | -514.00M | -895.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | 1.13B | 113.00 | 2.27% | ― | 5.17% | -65.33% | |
59 Neutral | 675.48M | -22.64 | -12.90% | ― | 11.76% | -42.52% | |
54 Neutral | 728.54M | -2.48 | -49.02% | ― | -14.33% | -398.68% | |
53 Neutral | $413.35M | ― | 39.18% | ― | 0.80% | -95.01% | |
52 Neutral | 391.33M | -3.03 | -24.11% | ― | -0.39% | -1408.40% | |
49 Neutral | 429.84M | -52.76 | -2.02% | ― | -24.30% | -210.27% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
On September 10, 2025, Community Health Systems, Inc. announced the appointment of Kevin J. Hammons as Interim Chief Executive Officer, effective October 1, 2025, following the retirement of Tim L. Hingtgen. Concurrently, Jason K. Johnson was appointed as Interim Chief Financial Officer, replacing Hammons. These leadership changes, previously announced in July 2025, are accompanied by revised compensation arrangements for both executives, including increased base salaries and enhanced cash incentive opportunities tied to company performance goals for the remainder of 2025.
The most recent analyst rating on (CYH) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
On August 12, 2025, Community Health Systems, Inc. completed its offering of $1.79 billion in 9.750% Senior Secured Notes due 2034, which are guaranteed by the company and its subsidiaries. The proceeds from this offering, along with cash on hand, were used to repurchase a significant portion of its outstanding 5.625% Senior Secured Notes due 2027, with plans to refinance the remaining balance. This strategic financial maneuver aims to optimize the company’s debt structure and improve its financial flexibility.
The most recent analyst rating on (CYH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.
On July 28, 2025, Community Health Systems, Inc. announced that its subsidiary priced an offering of $1,790 million in Senior Secured Notes due 2034, an increase from the initially proposed $1,500 million. The proceeds will be used to refinance existing notes due in 2027. Additionally, the company launched a cash tender offer for its 2027 Notes, increasing the offer size by $287 million. This financial maneuver aims to strengthen the company’s financial position by managing its debt obligations more effectively.
The most recent analyst rating on (CYH) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on Community Health stock, see the CYH Stock Forecast page.